Completed
Efficacy Study of Imatinib Mesylate to Treat Philadelphia-Positive Acute Lymphocytic Leukemia
NCT00154349
- Conditions
- Philadelphia Chromosome Positive Acute Lymphocytic Leukemia
- Locations
-
Not specified